FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

447079001: Conventional release orodispersible tablet (dose form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2881899019 Orodispersible tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3564270013 Conventional release orodispersible tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3564271012 Conventional release orodispersible tablet (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4852021000005117 smeltetablet da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)
4852031000005119 smeltetabletter da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Orodispersible tablet Is a Oral tablet false Inferred relationship Some
Orodispersible tablet Is a Oromucosal dose form (dose form) false Inferred relationship Some
Orodispersible tablet Has dose form administration method (attribute) Administer (administration method) false Inferred relationship Some
Orodispersible tablet Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. Oromucosal false Inferred relationship Some
Orodispersible tablet Has dose form release characteristic (attribute) A release characteristic where a dose form displays a rate and time of release of the active substance(s) in the dose form based on their intrinsic properties. true Inferred relationship Some
Orodispersible tablet Has basic dose form (attribute) A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. true Inferred relationship Some
Orodispersible tablet Has dose form transformation (attribute) No transformation true Inferred relationship Some
Orodispersible tablet Has dose form administration method (attribute) A method of administration of a dose form by placing it in the mouth and allowing it to dissipate; the product is usually then swallowed. true Inferred relationship Some
Orodispersible tablet Is a Oral dose form true Inferred relationship Some
Orodispersible tablet Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration by swallowing. true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely prednisolone (as prednisolone sodium phosphate) 5 milligram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form True Orodispersible tablet Inferred relationship Some
Sapropterin dihydrochloride 100 mg orodispersible tablet Has manufactured dose form True Orodispersible tablet Inferred relationship Some
Product containing precisely calcium carbonate 1.5 gram and colecalciferol 25 microgram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form True Orodispersible tablet Inferred relationship Some

Start Page 2 of 2


This concept is not in any reference sets

Back to Start